rs2071226

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000169.3(GLA):​c.194+17A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00479 in 1,188,364 control chromosomes in the GnomAD database, including 231 homozygotes. There are 1,864 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0051 ( 28 hom., 190 hem., cov: 24)
Exomes 𝑓: 0.0048 ( 203 hom. 1674 hem. )

Consequence

GLA
NM_000169.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.0110

Publications

4 publications found
Variant links:
Genes affected
GLA (HGNC:4296): (galactosidase alpha) This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
RPL36A-HNRNPH2 (HGNC:48349): (RPL36A-HNRNPH2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring ribosomal protein L36a and heterogeneous nuclear ribonucleoprotein H2 (H') genes on chromosome X. The read-through transcript produces a protein with similarity to the protein encoded by the upstream locus, ribosomal protein L36a. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jan 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant X-101407693-T-C is Benign according to our data. Variant chrX-101407693-T-C is described in ClinVar as Benign. ClinVar VariationId is 193058.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.115 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLANM_000169.3 linkc.194+17A>G intron_variant Intron 1 of 6 ENST00000218516.4 NP_000160.1 P06280Q53Y83

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLAENST00000218516.4 linkc.194+17A>G intron_variant Intron 1 of 6 1 NM_000169.3 ENSP00000218516.4 P06280
RPL36A-HNRNPH2ENST00000409170.3 linkc.301-4243T>C intron_variant Intron 4 of 4 4 ENSP00000386655.4 H7BZ11

Frequencies

GnomAD3 genomes
AF:
0.00511
AC:
566
AN:
110784
Hom.:
28
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.000132
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00391
Gnomad ASJ
AF:
0.000380
Gnomad EAS
AF:
0.125
Gnomad SAS
AF:
0.00531
Gnomad FIN
AF:
0.00645
Gnomad MID
AF:
0.00424
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.00470
GnomAD2 exomes
AF:
0.0109
AC:
1992
AN:
182637
AF XY:
0.0100
show subpopulations
Gnomad AFR exome
AF:
0.000152
Gnomad AMR exome
AF:
0.000292
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.125
Gnomad FIN exome
AF:
0.00581
Gnomad NFE exome
AF:
0.000678
Gnomad OTH exome
AF:
0.00331
GnomAD4 exome
AF:
0.00475
AC:
5121
AN:
1077524
Hom.:
203
Cov.:
29
AF XY:
0.00485
AC XY:
1674
AN XY:
345174
show subpopulations
African (AFR)
AF:
0.000192
AC:
5
AN:
25998
American (AMR)
AF:
0.000313
AC:
11
AN:
35194
Ashkenazi Jewish (ASJ)
AF:
0.000260
AC:
5
AN:
19254
East Asian (EAS)
AF:
0.131
AC:
3956
AN:
30111
South Asian (SAS)
AF:
0.00464
AC:
249
AN:
53670
European-Finnish (FIN)
AF:
0.00641
AC:
260
AN:
40531
Middle Eastern (MID)
AF:
0.00122
AC:
5
AN:
4082
European-Non Finnish (NFE)
AF:
0.000267
AC:
220
AN:
823260
Other (OTH)
AF:
0.00903
AC:
410
AN:
45424
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
205
410
616
821
1026
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00512
AC:
567
AN:
110840
Hom.:
28
Cov.:
24
AF XY:
0.00572
AC XY:
190
AN XY:
33216
show subpopulations
African (AFR)
AF:
0.000131
AC:
4
AN:
30442
American (AMR)
AF:
0.00391
AC:
41
AN:
10499
Ashkenazi Jewish (ASJ)
AF:
0.000380
AC:
1
AN:
2634
East Asian (EAS)
AF:
0.125
AC:
438
AN:
3505
South Asian (SAS)
AF:
0.00571
AC:
15
AN:
2627
European-Finnish (FIN)
AF:
0.00645
AC:
38
AN:
5894
Middle Eastern (MID)
AF:
0.00463
AC:
1
AN:
216
European-Non Finnish (NFE)
AF:
0.000398
AC:
21
AN:
52830
Other (OTH)
AF:
0.00531
AC:
8
AN:
1507
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
16
32
49
65
81
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00165
Hom.:
68
Bravo
AF:
0.00619

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 07, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 22, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fabry disease Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
12
DANN
Benign
0.71
PhyloP100
-0.011
PromoterAI
-0.058
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071226; hg19: chrX-100662681; COSMIC: COSV54509725; COSMIC: COSV54509725; API